These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 32128637)
1. Health-related quality of life and health utilities in insulin-treated type 2 diabetes: the impact of related comorbidities/complications. Yfantopoulos J; Chantzaras A Eur J Health Econ; 2020 Jul; 21(5):729-743. PubMed ID: 32128637 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis. Tunis SL; Minshall ME; Conner C; McCormick JI; Kapor J; Yale JF; Groleau D Curr Med Res Opin; 2009 May; 25(5):1273-84. PubMed ID: 19366302 [TBL] [Abstract][Full Text] [Related]
3. Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications. Kontodimopoulos N; Pappa E; Chadjiapostolou Z; Arvanitaki E; Papadopoulos AA; Niakas D Eur J Health Econ; 2012 Feb; 13(1):111-20. PubMed ID: 21132558 [TBL] [Abstract][Full Text] [Related]
4. Health utility of type 2 diabetes patients using basal insulin in China: results from the BEYOND II study. Li C; Zhou H; Wang P Acta Diabetol; 2021 Mar; 58(3):329-339. PubMed ID: 33067724 [TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life of patients with type 2 diabetes mellitus at a tertiary care hospital in Ethiopia. Gebremariam GT; Biratu S; Alemayehu M; Welie AG; Beyene K; Sander B; Gebretekle GB PLoS One; 2022; 17(2):e0264199. PubMed ID: 35180266 [TBL] [Abstract][Full Text] [Related]
6. Utilities for treatment-related adverse events in type 2 diabetes. Shingler S; Fordham B; Evans M; Schroeder M; Thompson G; Dewilde S; Lloyd AJ J Med Econ; 2015 Jan; 18(1):45-55. PubMed ID: 25266815 [TBL] [Abstract][Full Text] [Related]
7. Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes. Ray JA; Boye KS; Yurgin N; Valentine WJ; Roze S; McKendrick J; Tucker DM; Foos V; Palmer AJ Curr Med Res Opin; 2007 Mar; 23(3):609-22. PubMed ID: 17355742 [TBL] [Abstract][Full Text] [Related]
8. Association of hypoglycaemia severity with clinical, patient-reported and economic outcomes in US patients with type 2 diabetes using basal insulin. Meneghini LF; Lee LK; Gupta S; Preblick R Diabetes Obes Metab; 2018 May; 20(5):1156-1165. PubMed ID: 29316141 [TBL] [Abstract][Full Text] [Related]
9. Estimation of the relationship between body mass index and EQ-5D health utilities in individuals with type 2 diabetes: evidence from the population-based KORA studies. Hunger M; Schunk M; Meisinger C; Peters A; Holle R J Diabetes Complications; 2012; 26(5):413-8. PubMed ID: 22699110 [TBL] [Abstract][Full Text] [Related]
10. The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Huang ES; Shook M; Jin L; Chin MH; Meltzer DO Diabetes Care; 2006 Feb; 29(2):259-64. PubMed ID: 16443870 [TBL] [Abstract][Full Text] [Related]
11. Health Utilities in Patients with Type 2 Diabetes in Taiwan. Chen CC; Chen JH; Chen CL; Lai TJ; Ko Y Healthcare (Basel); 2021 Dec; 9(12):. PubMed ID: 34946402 [TBL] [Abstract][Full Text] [Related]
12. Estimating the impact of changes in HbA1c, body weight and insulin injection regimen on health related quality-of-life: a time trade off study. Ridderstråle M; Evans LM; Jensen HH; Bøgelund M; Jensen MM; Ericsson Å; Jendle J Health Qual Life Outcomes; 2016 Jan; 14():13. PubMed ID: 26801908 [TBL] [Abstract][Full Text] [Related]
13. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease. Moore A; Young CA; Hughes DA Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280 [TBL] [Abstract][Full Text] [Related]
14. Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes. Eby EL; Van Brunt K; Brusko C; Curtis B; Lage MJ Clin Interv Aging; 2015; 10():991-1001. PubMed ID: 26124652 [TBL] [Abstract][Full Text] [Related]
15. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting. Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912 [TBL] [Abstract][Full Text] [Related]
16. Impact of Hypoglycemia on Health-Related Quality of Life among Type 2 Diabetes: A Cross-Sectional Study in Thailand. Pratipanawatr T; Satirapoj B; Ongphiphadhanakul B; Suwanwalaikorn S; Nitiyanant W J Diabetes Res; 2019; 2019():5903820. PubMed ID: 31772942 [TBL] [Abstract][Full Text] [Related]
17. Which Factors may reduce the Health-Related Quality of Life of Ecuadorian Patients with Diabetes? Romero-Naranjo F; Espinosa-Uquillas C; Gordillo-Altamirano F; Barrera-Guarderas F P R Health Sci J; 2019 Jun; 38(2):102-108. PubMed ID: 31260554 [TBL] [Abstract][Full Text] [Related]
18. Predictors of health-related quality of life among people with type II diabetes Mellitus in Ardabil, Northwest of Iran, 2014. Shamshirgaran SM; Ataei J; Iranparvar Alamdari M; Safaeian A; Aminisani N Prim Care Diabetes; 2016 Aug; 10(4):244-50. PubMed ID: 26654733 [TBL] [Abstract][Full Text] [Related]
19. Predictors of health-related quality of life in type II diabetic patients in Greece. Papadopoulos AA; Kontodimopoulos N; Frydas A; Ikonomakis E; Niakas D BMC Public Health; 2007 Jul; 7():186. PubMed ID: 17663782 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with psychological distress, behavioral impact and health-related quality of life among patients with type 2 diabetes mellitus. Co MA; Tan LS; Tai ES; Griva K; Amir M; Chong KJ; Lee YS; Lee J; Khoo EY; Wee HL J Diabetes Complications; 2015 Apr; 29(3):378-83. PubMed ID: 25666950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]